Literature DB >> 8180008

Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor.

P Nørgaard1, L Damstrup, K Rygaard, M Spang-Thomsen, H Skovgaard Poulsen.   

Abstract

Nine human small-cell lung cancer cell lines were treated with transforming growth factor beta 1 (TGF-beta 1). Seven of the cell lines expressed receptors for transforming growth factor beta (TGF-beta-r) in different combinations between the three human subtypes I, II and III, and two were receptor negative. Growth suppression was induced by TGF-beta 1 exclusively in the five cell lines expressing the type II receptor. For the first time growth suppression by TGF-beta 1 of a cell line expressing the type II receptor without coexpression of the type I receptor is reported. No effect on growth was observed in two cell lines expressing only type III receptor and in TGF-beta-r negative cell lines. In two cell lines expressing all three receptor types, growth suppression was accompanied by morphological changes. To evaluate the possible involvement of the retinoblastoma protein (pRb) in mediating the growth-suppressive effect of TGF-beta 1, the expression of functional pRb, as characterised by nuclear localisation, was examined by immunocytochemistry. Nuclear association of pRb was only seen in two of the five TGF-beta 1-responsive cell lines. These results indicate that in SCLC pRb is not required for mediation of TGF-beta 1-induced growth suppression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180008      PMCID: PMC1968900          DOI: 10.1038/bjc.1994.158

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

1.  Characterization of three new variant type cell lines derived from small cell carcinoma of the lung.

Authors:  L de Leij; P E Postmus; C H Buys; J D Elema; F Ramaekers; S Poppema; M Brouwer; A Y van der Veen; G Mesander; T H The
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

2.  A simple, rapid, and sensitive DNA assay procedure.

Authors:  C Labarca; K Paigen
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

3.  Structure and properties of the cellular receptor for transforming growth factor type beta.

Authors:  B O Fanger; L M Wakefield; M B Sporn
Journal:  Biochemistry       Date:  1986-06-03       Impact factor: 3.162

4.  Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.

Authors:  R F Tucker; G D Shipley; H L Moses; R W Holley
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

5.  Comparison of characteristics of human small cell carcinoma of the lung in patients, in vitro and transplanted into nude mice.

Authors:  S A Engelholm; M Spang-Thomsen; L L Vindeløv; N Brünner; M H Nielsen; F Hirsch; A Nielsen; H H Hansen
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1986-09

6.  Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.

Authors:  R Derynck; J A Jarrett; E Y Chen; D H Eaton; J R Bell; R K Assoian; A B Roberts; M B Sporn; D V Goeddel
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

7.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

8.  Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.

Authors:  C Knabbe; M E Lippman; L M Wakefield; K C Flanders; A Kasid; R Derynck; R B Dickson
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

9.  Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family.

Authors:  R de Martin; B Haendler; R Hofer-Warbinek; H Gaugitsch; M Wrann; H Schlüsener; J M Seifert; S Bodmer; A Fontana; E Hofer
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

10.  TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.

Authors:  S P Wu; D Theodorescu; R S Kerbel; J K Willson; K M Mulder; L E Humphrey; M G Brattain
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  8 in total

1.  Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.

Authors:  M A Lynch; T A Petrel; H Song; T J Knobloch; B C Casto; D Ramljak; L M Anderson; V DeGroff; G D Stoner; R W Brueggemeier; C M Weghorst
Journal:  Gene Expr       Date:  2001

2.  Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.

Authors:  A Franchi; O Gallo; I Sardi; M Santucci
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

3.  Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas.

Authors:  S R Amoroso; N Huang; A B Roberts; M Potter; J J Letterio
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

4.  Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta.

Authors:  C Wong; E M Rougier-Chapman; J P Frederick; M B Datto; N T Liberati; J M Li; X F Wang
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  Expression of cell cycle regulating factor mRNA in small cell lung cancer xenografts.

Authors:  M Krarup; H S Poulsen; M Spang-Thomsen
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

6.  Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.

Authors:  P Nørgaard; M Spang-Thomsen; H S Poulsen
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

7.  Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.

Authors:  Tania Fernandez; Stephanie Amoroso; Shellyann Sharpe; Gary M Jones; Valery Bliskovski; Alexander Kovalchuk; Lalage M Wakefield; Seong-Jin Kim; Michael Potter; John J Letterio
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

8.  Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.

Authors:  S Hougaard; P Nørgaard; N Abrahamsen; H L Moses; M Spang-Thomsen; H Skovgaard Poulsen
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.